Fosun International LTD Bio N Tech Se Transaction History

Fosun International LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$127.65 - $183.11 $30.9 Million - $44.3 Million	-242,102 Reduced 24.12%	761,538 $103 Million
Q2 2022 Aug 10, 2022	SELL	$123.25 - $186.24 $6.16 Million - $9.31 Million	-50,000 Reduced 4.75%	1,003,640 $150 Million
Q1 2022 May 11, 2022	SELL	$126.25 - $231.85 $66.6 Million - $122 Million	-527,137 Reduced 33.35%	1,053,640 $180 Million
Q2 2021 Aug 12, 2021	BUY	$113.32 - $241.49 $179 Million - $382 Million	1,580,777 New	1,580,777 $354 Million

328

40.6M

845K

1.23M

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.8B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

Get notified when there are updates to the investment portfolio of Fosun International LTD, based on Form 13F filings with the SEC.

Stay updated on Fosun International LTD with notifications on news.